Seminars in Pediatric Neurology
Volume 13, Issue 4 , Pages 201-207 , December 2006

The Office Management of Epilepsy

  • Peter Camfield, MD, FRCP(C)

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Peter Camfield, MD, FRCP(C), IWK Health Centre, 5850 University Ave, PO BOX 9700, Halifax, Nova Scotia B3K 6R8.
    • ,
  • Carol Camfield, MD, FRCP(C)

References 

  1. Camfield PR, Camfield CS, Dooley JM, et al. Epilepsy after a first unprovoked seizure in childhood. Neurology. 1985;35:1657–1660
  2. Hauser WA, Rich SS, Lee JR, et al. Risk of recurrent seizures after two unprovoked seizures. N Engl J Med. 1998;338:429–434
  3. Shinnar S, Berg AT, O’Dell C, et al. Predictors of multiple seizures in a cohort of children prospectively followed from the time of their first unprovoked seizure. Ann Neurol. 2000;48:140–147
  4. Van Donselaar CA, Geerts AT, Meulstee J, et al. Reliability of the diagnosis of a first seizure. Neurology. 1989;39:267–271
  5. Uldall P, Alving J, Hansen LK, et al. The misdiagnosis of epilepsy in children admitted to a tertiary epilepsy centre with paroxysmal events. Arch Dis Child. 2006;91:206–209
  6. Hindley D, Ali A, Robson C. Diagnoses made in a secondary care “fits, faints, and funny turns” clinic. Arch Dis Child. 2006;91:214–218
  7. Camfield PR, Camfield CS. Management issues in pediatric epilepsy. Semin Pediatr Neurol. 1994;1:71
  8. Stroink H, Schimsheimer RJ, de Weerd AW, et al. Interobserver reliability of visual interpretation of electroencephalograms in children with newly diagnosed seizures. Dev Med Child Neurol. 2006;48:374–377
  9. Camfield PR, Camfield CS. Childhood epilepsy: What is the evidence for what we think and what we do?. J Child Neurol. 2003;18:272–287
  10. Rinaldi G, Zarrelli MM, Beghi E, et al. The international classification of the epilepsies and epileptic syndromes (An algorithm for its use in clinical practice). Epilepsy Res. 2000;41:223–234
  11. Sazgar M, Bourgeois BF. Aggravation of epilepsy by antiepileptic drugs. Pediatr Neurol. 2005;33:227–234
  12. Guerrini R, Parmeggiani L, Bonanni P, et al. Myoclonic astatic epilepsy. In:  Roger M,  Dravet CH,  Genton P, et al. editor. Epileptic Syndromes in Infancy, Childhood and Adolescence. (ed 4).. London, UK: John Libbey Eurotext Ltd; 2005;p. 89–114
  13. Beaumanoir A, Blume W. The Lennox-Gastaut Syndrome. In:  Roger M,  Dravet CH,  Genton P, et al. editor. Epileptic Syndromes in Infancy, Childhood and Adolescence. (ed 4).. London, UK: John Libbey Eurotext Ltd; 2005;p. 115–124
  14. Carpay JA, de Weerd AW, Schimsheimer RJ, et al. The diagnostic yield of a second EEG after partial sleep deprivation: A prospective study in children with newly diagnosed seizures. Epilepsia. 1997;38:595–599
  15. Camfield P, Camfield C. How often does routine pediatric EEG have an important unexpected result?. Can J Neurol Sci. 2000;27:321–324
  16. Commission on classification and terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia. 1989;30:389–399
  17. Eeg-Olofsson O, Lundberg S, Raininko R. MRI in rolandic epilepsy. Epileptic Disord. 2000;2(suppl 1):S51–S53
  18. Freeman JM, Vining EPH, Pillas DJ. Seizures and Epilepsy in Childhood: A Guide for Parents. (ed 3).. Baltimore: The John Hopkins University Press; 2003;
  19. Camfield CS, Camfield PR, Veugelers P. Death in children with childhood onset epilepsy: A population-based study. Lancet. 2002;359:1892–1895
  20. Callenbach PM, Westendorp RG, Geerts AT, et al. Mortality risk in children with epilepsy: The Dutch study of epilepsy in childhood. Pediatrics. 2001;107:1259–1263
  21. Camfield P, Camfield C, Smith D, et al. Home use of rectal diazepam to prevent status epilepticus in children with convulsive disorders. J Child Neurol. 1989;4:125–126
  22. Scott RC, Besag FM, Neville BG. Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: A randomised trial. Lancet. 1999;353:623–626
  23. Appleton R, Sweeney A, Choonara I, et al. Lorazepam versus diazepam in the acute treatment of epileptic seizures and status epilepticus. Dev Med Child Neurol. 1995;37:682–688
  24. Fisgin T, Gurer Y, Tezic T, et al. Effects of intranasal midazolam and rectal diazepam on acute convulsions in children: Prospective randomized study. J Child Neurol. 2002;17:123–126
  25. Commission of Pediatrics of the ILAEInternational League Against Epilepsy. ILAE Commission report (Restrictions for children with epilepsy). Epilepsia. 1997;38:1054–1056
  26. Wirrell EC, Camfield PR, Camfield CS, et al. Accidental injury is a serious risk in children with typical absence epilepsy. Arch Neurol. 1996;53:929–932
  27. Peters JM, Camfield CS, Camfield PR. Population study of benign rolandic epilepsy: Is treatment needed?. Neurology. 2001;57:537–539
  28. Camfield PR, Camfield CS, Lye CA. Pirouetting tap. Epilepsia. 2005;46:1153
  29. Jeavons PM, GF Harding. In: Photosensitivie Epilepsy. London: Mac Keith Press; 1994;p. 149
  30. Gordon E, Devinsky O. Alcohol and marijuana: Effects on epilepsy and use by patients with epilepsy. Epilepsia. 2001;42:1266–1272
  31. Gross DW, Hamm J, Ashworth NL, et al. Marijuana use and epilepsy: Prevalence in patients of a tertiary care epilepsy center. Neurology. 2004;62:2095–2097
  32. Camfield CS, Camfield PR, Gordon KG, et al. Does the number of seizures before treatment influence ease of control or remission of childhood epilepsy? (Not if the number is less than 10). Neurology. 1996;46:41–44
  33. Marson A, Jacoby A, Johnson A, et al. Medical Research Council MESS Study Group Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: A randomised controlled trial. Lancet. 2005;365:2007–2013
  34. Camfield PR, Camfield CS. Clinical evidence that epilepsy is not a progressive disorder with special emphasis on epilepsy syndromes that do not progress. Adv Neurol. 2005;97:315–322
  35. Camfield CS, Camfield PR, Gordon KE, et al. Predicting the outcome of childhood epilepsy—A population based study yielding a simple scoring system. J Pediatr. 1993;122:861–868
  36. Camfield PR, Camfield CS, Gordon K, et al. If a first antiepileptic drug fails to control a child’s epilepsy, what are the chances of success with the next drug?. J Pediatr. 1997;131:821–824
  37. Wheless JW, Neto W, Wang S EPMN-105 Study Group. Topiramate, carbamazepine, and valproate monotherapy: Double-blind comparison in children with newly diagnosed epilepsy. J Child Neurol. 2004;19:135–141
  38. Posner EB, Mohamed K, Marson AG. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents. Cochrane Database Syst Rev. 2005;4:CD003032
  39. Austin JK, Dunn DW, Caffrey HM, et al. Recurrent seizures and behavior problems in children with first recognized seizures: A prospective study. Epilepsia. 2002;43:1564–1573
  40. Fastenau PS, Shen J, Dunn DW, et al. Neuropsychological predictors of academic underachievement in pediatric epilepsy: Moderating roles of demographic, seizure, and psychosocial variables. Epilepsia. 2004;45:1261–1272
  41. Austin JK, Dunn DW, Johnson CS, et al. Behavioral issues involving children and adolescents with epilepsy and the impact of their families: Recent research data. Epilepsy Behav. 2004;5(suppl 3):S33–S41
  42. Camfield CS, Breau LM, Camfield PR. Assessing the impact of pediatric epilepsy and concomitant behavioral, cognitive, and physical/neurologic disability: Impact of Childhood Neurologic Disability Scale. Dev Med Child Neurol. 2003;43:152–159
  43. Jalava M, Sillanpaa M, Camfield C, et al. Social adjustment and competence 35 years after onset of childhood epilepsy: A prospective controlled study. Epilepsia. 1997;38:708–715
  44. Wirrell E, Camfield CS, Camfield PR, et al. Long-term psychosocial outcome in typical absence epilepsy: Sometimes a wolf in sheep’s clothing. Arch Pediatr Adol Med. 1997;151:152–158
  45. Achenbach TM. Manual for the Child Behavior Checklist/4-18 and 1991 profile. Burlington, VT: University of Vermont Department of Psychiatry; 1991;
  46. Ireton HR. Child Development Inventory Manual. Minneapolis, MN: Behavior Science Systems; 1992;
  47. Camfield CS, Breau LM, Camfield PR. Impact of pediatric epilepsy on the family: A new scale for clinical and research use. Epilepsia. 2001;42:104–112
  48. Oostrom KJ, van Teeseling H, Smeets-Schouten A, et al. Dutch Study of Epilepsy in Childhood (DuSECh) (Three to four years after diagnosis: cognition and behaviour in children with ‘epilepsy only’. A prospective, controlled study). Brain. 2005;128:1546–1555
  49. Jannuzzi G, Cian P, Fattore C, et al. The Italian TDM Study Group in Epilepsy A multicenter randomized controlled trial on the clinical impact of therapeutic drug monitoring in patients with newly diagnosed epilepsy. Epilepsia. 2000;41:222–230
  50. Woo E, Chan YM, Yu YL, et al. If a well-stabilized epileptic patient has a subtherapeutic antiepileptic drug level, should the dose be increased? (A randomized prospective study). Epilepsia. 1988;29:129–139
  51. Froscher W, Eichelbaum M, Gugler R, et al. A prospective randomised trial on the effect of monitoring plasma anticonvulsant levels in epilepsy. J Neurol. 1981;224:193–201
  52. Dooley JM, Camfield PR, Camfield CS, et al. The use of antiepileptic drug levels in children: A survey of Canadian pediatric neurologists. Can J Neurol Sci. 1993;20:217–221
  53. Camfield PR, Camfield CS, Dooley J, et al. Routine screening of blood and urine for severe reactions to anticonvulsant drugs in asymptomatic patients is of doubtful value. Can Med Assoc J. 1989;140:1303–1305
  54. Camfield CS, Camfield PR, Smith E, et al. Asymptomatic children with epilepsy: Little benefit from screening for anticonvulsant-induced liver, blood or renal damage. Neurology. 1986;36:838–841
  55. Sheth RD. Bone health in pediatric epilepsy. Epilepsy Behav. 2004;5(suppl 2):S30–S35
  56. Sillanpaa M. Children with epilepsy as adults: Outcome after 30 years of follow-up. Acta Paediatr Scand Suppl. 1990;368:1–78
  57. Sillanpaa M, Schmidt D. Natural history of treated childhood-onset epilepsy: Prospective, long-term population-based study. Brain. 2006;129:617–624
  58. Berg AT, Shinnar S. Relapse following discontinuation of anti-epileptic drugs: Meta-analysis. Neurology. 1994;44:601–608
  59. Dooley JM, Gordon K, Camfield PR, et al. Discontinuation of anticonvulsant therapy in children free of seizures for 1 year. Neurology. 1996;46:969–974
  60. Peters AC, Brouwer OF, Geerts AT, et al. Randomized prospective study of early discontinuation of AED’s in children with epilepsy. Neurology. 1998;50:724–730
  61. Braathen G, Anderson T, Gylie H, et al. Comparison between one and three years of treatment in uncomplicated childhood epilepsy: A prospective study. 1. Outcome in different seizure types. Epilepsia. 1996;37:822–832
  62. Arts WF, Brouwer OF, Peters AC, et al. Course and prognosis of childhood epilepsy: 5-year follow-up of the Dutch study of epilepsy in childhood. Brain. 2004;127:1774–1784
  63. Camfield PR, Camfield CS. The frequency of intractable seizures after stopping AEDs in seizure-free children with epilepsy. Neurology. 2005;64:973–975
  64. Berg AT, Shinnar S, Levy SR, et al. Two-year remission and subsequent relapse in children with newly diagnosed epilepsy. Epilepsia. 2001;42:1553–1562
  65. Appleton RE, Chadwick D, Sweeney A. Managing the teenager with epilepsy: Paediatric to adult care. Seizure. 1997;6:27–30

PII: S1071-9091(06)00124-0

doi: 10.1016/j.spen.2006.09.001

Seminars in Pediatric Neurology
Volume 13, Issue 4 , Pages 201-207 , December 2006

Article Tools